CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing ...
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...
The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better ...
Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...
MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...
Rick Abramson, a radiologist by training and the director of FDA's Digital Health Center of Excellence said, "We ended up ...
In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...
The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...
Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out ...
The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results